In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin.
Ann Intern Med
; 176(1): JC9, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-36592466
ABSTRACT
SOURCE CITATION GRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;3871075-88. 36129997.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 2
Límite:
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article